

Evaluate Pharma is a leading pharmaceutical market intelligence platform that helps biopharma companies, investors, consultants, and business development teams make faster, more confident strategic decisions. Built on trusted industry data and consensus forecasts, the platform provides a connected view of the global pharmaceutical landscape, bringing together product pipelines, company intelligence, sales performance, and market forecasts in a single environment. The platform offers extensive coverage of the pharmaceutical and biotech industry, including thousands of companies and products, millions of consensus forecasts, historical sales data, and detailed intelligence at the company, product, and indication level. Advanced reporting, data visualization, export capabilities, and AI-powered search functionality help users quickly uncover insights and transform complex data into actionable recommendations. Whether you are assessing asset potential, sizing markets, identifying growth opportunities, monitoring competitors, or supporting investment decisions, Evaluate Pharma delivers the trusted intelligence needed to navigate the rapidly evolving life sciences market with confidence.
Biomedtracker is your go-to platform for real-time analysis of commercial, clinical, and regulatory activities. With an easily searchable interface, automated alerts, and human insight you’ll always be one step ahead of the competition. Our analysts provide context to major market events, detailing what happened, what’s next, and why it matters. Cut through the noise and gain a deeper understanding of the impact on your business with Biomedtracker. Real-Time Intelligence: Access essential market data on drugs, companies, indications, deals, targets, catalysts, endpoint data, trials, and more—all at your fingertips. Future Insights: Make high-impact clinical, commercial, and regulatory decisions with confidence. Biomedtracker keeps you updated on the evolving drug development landscape with reliable forecasts and proprietary drug approval metrics. Data Driven Decisions Leverage Biomedtracker’s Quarterly Outlook reports and conference coverage to make informed, data-driven decisions with insights from top industry analysts. Business Development & Licensing: Access essential market data on drugs, companies, indications, deals, targets, catalysts, endpoint data, trials, and more—all at your fingertips. Portfolio & Strategy: Maintain a long-term view of the market to make timely decisions, diversify risk, and optimize your pipeline for the long-term. Competitive Intelligence: Track the market, monitor the landscape and know what’s around the corner.
There’s too much at stake in drug development to rely on uncertainty. We bring foresight to the forefront, turning complex data into confident direction — helping pharma innovators and investors move smarter, from investment to launch.